^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
RD13-02
i
Other names: RD13-02
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Nanjing Bioheng Biotech
Drug class:
CD7-targeted CAR-T immunotherapy
Related drugs:
